海外の治験の状況「1」での検索結果
10032件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Recruiting
- The effect of eight weeks aerobic exercise on endothelin-1, nitric oxide, malondialdehyde, serum 8 hydroxydeoxyguanosine and uric 8 hydroxydeoxyguanosine in elderly women
- Cardiovascular risk factor. Atherosclerosis
- Iran (Islamic Republic of)
- 2018-03-15
Not Recruiting
- Clinical study of Apatinib combined with chemotherapy or single Drug for second-line treatment failure in advanced ovarian cancer
- ovarian cancer
- China
- 2018-03-14
Recruiting
- Cetuximab Therapy for Third Line Rechallenge in Metastatic Colorectal Cancer
- Cancer of Colon;Cancer of Colon;Cancer of Colon
- Israel
- 2018-03-07
Recruiting
- Osimertinib as First-line Therapy for Patients With Late-stage Lung Cancer
- Non-small Cell Lung Cancer;Non-small Cell Lung Cancer;Non-small Cell Lung Cancer
- China
- 2018-03-05
Recruiting
- A randomized, parallel and multicenter study of the intervention effects of three chemotherapy regimens in patients with first-line metastatic esophageal squamous cell carcinoma
- metastatic esophageal squamous cell carcinoma
- China
- 2018-03-05
Recruiting
- Third-line therapy with apatinib in metastatic colorectal cancer: individualized dose adjustment based on plasma concentration and adverse reactions
- Metastatic colorectal cancer
- China
- 2018-03-05
Recruiting
- Apatinib mesylate tablets for the maintain treatment of platinum-sensitive recurrent ovarian cancer after first-line chemotherapy: a prospective, one-arm clinical study
- Ovarian cancer
- China
- 2018-02-26
Not recruiting
- Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.
- Metastatic Colorectal Cancer
- Australia, Austria, Brazil, Denmark, Estonia, France, Ireland, Italy, Lithuania, Russian Federation, Spain, Sweden, United Kingdom
- 2018-02-23
Authorised
- Phase III study in first-line treatment of patients with metastatic colorectal cancer who are not candidate for intensive therapy
- Metastatic colorectal cancer MedDRA version: 20.0 Level: PT Classification code 10052358 Term: Colorectal cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Austria, Brazil, Bulgaria, Colombia, Czech Republic, Denmark, Estonia, France, Germany, Hungary, Ireland, Italy, Latvia, Lithuania, Netherlands, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Sweden, Turkey, Ukraine, United Kingdom
- 2018-02-12
Recruiting
- BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma
- Esophageal, Gastric, or Gastroesophageal Junction Carcinoma
- China
- 2018-02-08
Recruiting
- SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer
- Locally Advanced or Metastatic Pancreatic Cancer;Locally Advanced or Metastatic Pancreatic Cancer;Locally Advanced or Metastatic Pancreatic Cancer
- Taiwan
- 2018-02-08
Recruiting
- To Study the success and safety of putting central line in two different Neck veins for faster administration of fluids and drugs in cardiac surgery patients
- patients undergoing all types of cardiac surgeries in the dept of cardiothoracic anaesthesia of the institution
- India
- 2018-01-31
Recruiting
- A Phase ? Study to Investigate JS001 Versus Dacarbazine as the First Line Therapy for Unresectable or Metastatic Melanoma
- Metastatic Melanoma;Unresectable Melanoma;Metastatic Melanoma;Unresectable Melanoma;Metastatic Melanoma;Unresectable Melanoma
- China
- 2018-01-29
Recruiting
- A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Patients With Advanced Esophageal Squamous Cell Carcinoma
- Esophageal Squamous Cell Carcinoma (ESCC)
- Belgium, China, France, Italy, Japan, Korea, Republic of, Spain, Taiwan, United Kingdom, United States
- 2018-01-29
Authorised
- Phase III study in first-line treatment of patients with metastatic colorectal cancer who are not candidate for intensive therapy
- Metastatic colorectal cancer MedDRA version: 20.0 Level: PT Classification code 10052358 Term: Colorectal cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Austria, Brazil, Bulgaria, Colombia, Czech Republic, Denmark, Estonia, France, Germany, Hungary, Ireland, Italy, Latvia, Lithuania, Netherlands, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Sweden, Turkey, Ukraine, United Kingdom
- 2018-01-25
Not recruiting
- Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens
- HIV Infections
- Thailand
- 2008-02-21
Not recruiting
- Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer
- Metastatic Breast Cancer
- Belgium, Brazil, Germany, Israel, Ukraine, United States
- 2008-02-01
Not recruiting
- A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen
- Colorectal Neoplasms;Colorectal Neoplasms;Colorectal Neoplasms;Colorectal Neoplasms
- Belgium, Canada, Czech Republic, France, Italy, Japan, Korea, Republic of, Poland, Spain, United States
- 2008-02-01
Not recruiting
- Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer
- Lung Cancer
- Korea, Republic of
- 2008-01-25
Not recruiting
- SELINE: Second-Line Iressa Phase IV Study in NSCLC Patients
- Non Small Cell Lung Carcinoma;Non Small Cell Lung Carcinoma;Non Small Cell Lung Carcinoma;Non Small Cell Lung Carcinoma
- Korea, Republic of
- 2008-01-23